MEREO BIOPHARMA - 53 Year Dividend History | MREO

Historical dividend payout and yield for MEREO BIOPHARMA (MREO) since 1971. The current TTM dividend payout for MEREO BIOPHARMA (MREO) as of May 22, 2024 is $0.00. The current dividend yield for MEREO BIOPHARMA as of May 22, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.419B $0.010B
Mereo BioPharma Group PLC is a biopharmaceutical company. It is focused on development and commercialization of therapeutics for patients with rare diseases. The company's product pipeline includes BPS-804, MPH-966, BCT-197, BGS-649, Navicixizumab and Etigilimab which are in clinical stage. Mereo BioPharma Group PLC is based in London, United Kingdom.
Stock Name Country Market Cap PE Ratio